Investigating the role of omega-3 fatty acids in treating nerve damage from diabetes
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Diabetic Peripheral Neuropathy:Is the source important?
This study is looking at whether omega-3 fatty acids, like those found in fish oil, can help repair nerve damage in veterans with type 2 diabetes who have diabetic peripheral neuropathy, and it hopes to find new ways to improve their nerve health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Iowa City VA Medical Center NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10854778 on NIH RePORTER |
What this research studies
This research focuses on the potential of omega-3 polyunsaturated fatty acids (PUFAs) to repair nerve damage caused by diabetic peripheral neuropathy (DPN), particularly in veterans with type 2 diabetes. The study aims to determine whether the source of omega-3s, such as fish oil, influences their effectiveness in promoting nerve repair. By examining the anti-inflammatory and neuroprotective properties of specific omega-3 metabolites, the research seeks to establish a new treatment pathway for DPN, which currently has limited options. Patients may be involved in clinical trials that assess the impact of these fatty acids on their nerve health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with type 2 diabetes who are experiencing symptoms of diabetic peripheral neuropathy.
Not a fit: Patients without diabetes or those who do not have diabetic peripheral neuropathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option for patients suffering from diabetic peripheral neuropathy, potentially improving their quality of life.
How similar studies have performed: Previous studies have shown promising results with omega-3 fatty acids in animal models, but this research aims to explore their effectiveness in human patients, making it a novel approach.
Where this research is happening
Iowa City, United States
- Iowa City VA Medical Center — Iowa City, United States (Active)
Researchers
- Principal investigator: Yorek, Mark a. — Iowa City VA Medical Center
- Study coordinator: Yorek, Mark a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.